u/liv_vukovic

Inter-lab variance on this kind of assay is routinely 1–2 points.

Disagree on that part. 97.4% and 97.6% on the same vial is normal.

state board rules differ, say which state

Canada plan: step therapy required 24 medications first. Did them all, got approval. The order matters.

the MASH indication changes the risk calculus

telehealth costs 503A plus compounding markup, total varies

Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.

Strongly agree. Step therapy is predictable if you have the criteria.

the GLP-1/glucagon dual is hepatic fat, different from GIP/GLP-1

I am going to push back on this slightly.

You have restated the marketing copy. What is the actual substance here.

the carve-out clause varies by employer

The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.

redact member ids and group numbers from every screenshot

week 42 and the constipation is finally getting better

My early fullness was worst at 15mg and better at 12.5mg, which makes no sense but it is real.

prior auth criteria are state-specific, formulary differs

formulary exclusions are negotiable sometimes

the the UK situation is different from the US, different regulations

the shortage list is temporary, it ends and compounding becomes illegal again

nausea on day 2 is normal, nausea after week 61 is worth checking